We are live on ! Find out more
GP

Geneva Partners Portfolio holdings

AUM $375M
1-Year Est. Return 131.24%
This Fund
S&P 500
This Quarter Est. Return
+13.17%
1 Year Est. Return
+131.24%
3 Year Est. Return
+400.69%
5 Year Est. Return
+687.84%
10 Year Est. Return
AUM
$164M
AUM Growth
+$20.9M
Cap. Flow
+$6.35M
Cap. Flow %
3.89%
Top 10 Hldgs %
36.15%
Holding
99
New
21
Increased
33
Reduced
25
Closed
18

Top Buys

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$5.23M
2
QCOM icon
Qualcomm
QCOM
+$4.02M
3
CMI icon
Cummins
CMI
+$2.46M
4
QRVO icon
Qorvo
QRVO
+$2.46M
5
NKE icon
Nike
NKE
+$2.46M

Top Sells

Rank Stock Value
1
TEAM icon
Atlassian
TEAM
+$3.14M
2
TER icon
Teradyne
TER
+$2.64M
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$2.19M
4
CNC icon
Centene
CNC
+$1.94M
5
VEEV icon
Veeva Systems
VEEV
+$1.63M

Sector Composition

Rank Sector Weight
1 Miscellaneous 20.45%
2 Healthcare 16.22%
3 Technology 15.64%
4 Consumer Discretionary 13.82%
5 Communication Services 10.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UNP icon
76
Union Pacific
UNP
$169B
$250K 0.15%
+1,270
New +$236K
IBDM
77
DELISTED
iShares iBonds Dec 2021 Term Corporate ETF
IBDM
$230K 0.14%
+9,197
New +$231K
IHI icon
78
iShares US Medical Devices ETF
IHI
$3.26B
$223K 0.14%
+4,458
New +$216K
IWB icon
79
iShares Russell 1000 ETF
IWB
$48.4B
$220K 0.13%
1,175
+2
+0.2% +$369
HYG icon
80
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$15.1B
$201K 0.12%
+2,393
New +$201K
BTG icon
81
B2Gold
BTG
$6.9B
$150K 0.09%
23,000
+8,000
+53% +$52K
AMD icon
82
Advanced Micro Devices
AMD
$823B
-27,685
Closed -$1.46M
BMRN icon
83
BioMarin Pharmaceuticals
BMRN
$12.5B
-2,765
Closed -$341K
CNC icon
84
Centene
CNC
$33.4B
-30,595
Closed -$1.94M
ECL icon
85
Ecolab
ECL
$77B
-6,534
Closed -$1.3M
FTNT icon
86
Fortinet
FTNT
$126B
-10,575
Closed -$290K
HUM icon
87
Humana
HUM
$47.6B
-874
Closed -$339K
JKHY icon
88
Jack Henry & Associates
JKHY
$10.8B
-2,840
Closed -$523K
JNJ icon
89
Johnson & Johnson
JNJ
$644B
-3,300
Closed -$464K
MRVL icon
90
Marvell Technology
MRVL
$199B
-14,390
Closed -$505K
REGN icon
91
Regeneron Pharmaceuticals
REGN
$79.7B
-3,518
Closed -$2.19M
TEAM icon
92
Atlassian
TEAM
$48B
-17,420
Closed -$3.14M
TECH icon
93
Bio-Techne
TECH
$11.3B
-9,660
Closed -$638K
TER icon
94
Teradyne
TER
$52B
-31,285
Closed -$2.64M
TW icon
95
Tradeweb Markets
TW
$21.4B
-7,980
Closed -$464K
UNH icon
96
UnitedHealth
UNH
$337B
-3,284
Closed -$969K
ZBRA icon
97
Zebra Technologies
ZBRA
$16.2B
-1,262
Closed -$323K
SPLK
98
DELISTED
Splunk Inc
SPLK
-1,270
Closed -$252K
COUP
99
DELISTED
Coupa Software Incorporated
COUP
-1,270
Closed -$352K

Similar funds

Geneva Partners's Q3 2020 Portfolio in Review

As of Q3 2020, Geneva Partners held 99 positions worth $164M, up 15% from $143M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Geneva Partners deployed $6.35M of net new capital in Q3 2020, opening 21 new positions and adding to 33 existing holdings. Its largest new stake was Alibaba: 19,869 shares worth $5.84M.

By sector, the portfolio is most concentrated in Miscellaneous at 20% of assets, up from 20% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Veeva Systems, an estimated $1.63M trimmed.

  • Geneva Partners's largest Q3 2020 buy was Alibaba: 19,869 shares worth $5.84M.
  • Geneva Partners added most to Qualcomm in Q3 2020, an estimated $4.02M increase.
  • Geneva Partners's biggest Q3 2020 reduction was Veeva Systems, cutting an estimated $1.63M.
  • Geneva Partners fully exited Atlassian in Q3 2020, selling an estimated $3.14M.
  • Geneva Partners's ten largest holdings make up 36% of its $164M portfolio in Q3 2020.
  • Geneva Partners opened 21 new positions and closed 18 in Q3 2020.
  • Geneva Partners's portfolio value rose 15% quarter-over-quarter to $164M.

Based on Geneva Partners's 13F filing for Q3 2020, filed 28 Oct 2020.